I

Iconic Therapeutics, Inc.

11 employees

Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Therapeutics
Biopharma

Date founded

2002

Funding rounds raised

Total raised

$40M

from 26 investors over 26 rounds

I

Iconic Therapeutics, Inc. raised $4.1M on June 15, 2018

Investors: H.I.G. BioVentures, Lundbeckfonden / Lundbeck Foundation, MPM Capital, Elm Street Ventures, JLABS, HBM Partners AG and Osage University Partners (OUP)

I

Iconic Therapeutics, Inc. raised $10M on August 9, 2016

Investors: H.I.G. BioVentures, Lundbeckfonden / Lundbeck Foundation, MPM Capital, Osage University Partners (OUP) and Xeraya Capital

I

Iconic Therapeutics, Inc. raised $40M on January 11, 2016

Investors: Lundbeckfonden / Lundbeck Foundation, MPM Capital, H.I.G. Capital and Osage University Partners (OUP)

I

Iconic Therapeutics, Inc. raised $20M on April 16, 2014

Investors: Lundbeckfonden / Lundbeck Foundation, H.I.G. BioVentures and MPM Capital

I

Iconic Therapeutics, Inc. raised undisclosed on August 22, 2011

Investors: ATDC

I

Iconic Therapeutics, Inc. raised $100K on July 12, 2010

Investors: Georgia Research Alliance

I

Iconic Therapeutics, Inc. raised $150K on April 9, 2010

Investors: Georgia Research Alliance

I

Iconic Therapeutics, Inc. raised $50K on January 12, 2010

Investors: Georgia Research Alliance

I

Iconic Therapeutics, Inc. raised $48K on August 31, 2009

Investors: Georgia Research Alliance

I

Iconic Therapeutics, Inc. raised $2.5M on January 17, 2009

Investors: ATDC and Elm Street Ventures

FAQ